Sign inMedRx among first companies to onboard new NAL-NL3 Fitting Formula
MedRx Inc. is a U.S. based, Demant-owned global manufacturer and developer of advanced computerised diagnostic and hearing instrument fitting technologies. As audiologists worldwide begin to transition from the highly popular NL2 fitting prescription to the new NL3, MedRx is right there in the front line.
Computerised equipment outfit MedRx has been working with Australia’s National Acoustic Laboratories (NAL) to bring the next-generation NAL-NL3 fitting formula to MedRx’s verification and testing systems, making the Demant-owned manufacturer of the world’s first companies to implement NL3
The NAL stand at the recent EUHA Congress in Germany. Photo: PW
This integration—now available in MedRx Studio Software version 1.3.2—marks one of the first implementations of NAL-NL3 worldwide. This racially updated fitting software version represents a major step forward in personalisation of fitting, bringing far greater precision to the process.
Key highlights of the MedRx integration of NAL-NL3
- NAL-NL3 is the latest evidence-based fitting system designed to optimise speech intelligibility and listening comfort.
- MedRx Studio v1.3.2 now supports NAL-NL3 across REM/LSM and HIT workflows.
- Compatible with MedRx AVANT HIT+, AVANT REM+, AVANT ARC, WREM, and AWRC systems.
- Clinicians can verify fittings using real-ear measurements and confirm device performance in the HIT box—all aligned to NAL-NL3 targets.
- This release underscores how research and industry collaboration can translate into faster access to evidence-based tools for hearing care professionals worldwide.
MedRx among first to use new formula
“MedRx is committed to delivering cutting-edge tools for hearing care professionals. Integrating NAL-NL3 into our software reflects our dedication to best practices and innovation,” said Caleb Sparkman, President, MedRx.
Brent Edwards, Director of NALPhoto: PW
Meanwhile, Brent Edwards, Director of the National Acoustic Laboratories, underlined the swiftness of MedRx in implementing the new prescription:”This makes MedRx the first verification systems globally to integrate and offer the NAL-NL3 Fitting System, including the two new modules for special use cases.”
“Clinicians now have access to the most advanced fitting formula available today, helping them deliver even better outcomes for people with hearing difficulties,” added Edwards.
Clinicians can access NAL-NL3 by updating to MedRx Studio Software v1.3.2. For more information on the prescription, click here.
And for a bigger picture from MedRx, click here.
Source: MedRx
